Of these pro-inflammatory cytokines interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor α (TNFα) have been previously described in esophageal cancer and associations with several clinicopathological parameters have been shown [16–18]. This evidence concerns the gene IL6 and esophageal cancer.